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Abstract We review the biofunctional effects of the flower
buds ofCamellia sinensis andC. sinensis var. assamica, such
as antihyperlipidemic, antihyperglycemic, antiobesity, and
gastroprotective effects in vivo, and antiallergic, pancreatic
lipase inhibitory, and amyloid b (Ab) aggregation inhibitory
activities in vitro. Although the biofunctional effects of tea
leaves have been extensively studied, less attention has been
given to those of the flowers and seeds of the tea plant. Our
studies focused on the saponin constituents of the extracts of
the flower buds of C. sinensis cultivated in Japan and China,
and C. sinensis var. assamica cultivated in India, and we
review their beneficial biofunctions for health promotion.
Keywords Camellia sinensis  Camellia sinensis var.
assamica  Flower buds  Chakasaponin 
Floratheasaponin  Floraassamsaponin  Biofunctional
effect
Introduction
Tea made from the leaves of the plant Camellia sinensis
has been used since ancient times for medicinal purposes,
and is now consumed as a popular beverage. Cultivated in
more than 30 countries,[4 million tons of tea are produced
annually. Depending on the processing of the leaves, tea is
classified into two major types—green tea and black tea.
While black tea is the major type of tea produced and
consumed worldwide, green tea is more popular than black
tea in China and Japan. Tea has been studied for its ben-
eficial health effects, such as reduction of body weight,
alleviation of metabolic syndrome, prevention of cardio-
vascular diseases and cancer, and protection against neu-
rodegeneration. With regard to the mechanisms responsible
for metabolic syndrome, decreased absorption of lipids by
tea polyphenols such as (-)-epigallocatechin 3-O-gallate at
the intestine, and activation of adenosine monophosphate
(AMP)-activated protein kinase by tea polyphenols that are
bioavailable in the liver, skeletal muscle, and adipose tis-
sues have been demonstrated. Activation of AMP-activated
protein kinase decreases gluconeogenesis and fatty acid
synthesis and increases catabolism, leading to body weight
reduction and alleviation of metabolic syndrome [1].
Although the biofunctional effects of tea leaves have
been studied extensively, less attention has been given to
those of the flowers and seeds of the tea plant. We have
previously reported the various tea saponins, asssam-
saponins, and camelliasaponins (classified as acylated
oleanane-type triterpene oligogycosides) from the seeds of
C. sinensis and C. sinensis var. assamica [2–9]. Among
them, theasaponins E1, E2, E5, and assamsaponin C (at a
low dose of 5.0 mg/kg) showed protective effects on
ethanol-induced gastric mucosal lesions in rats [3, 5, 6],
and theasaponin E1 inhibited gastric emptying, and elicited
an accelerating effect on gastrointestinal transit [4].
Foliatheasaponins from the leaves of Japanese C. sinensis
(Tencha) have also been reported to display such effects
[10]. With regard to the biofunctions of the tea flower
(‘Chaka’ in Japanese), we have reported the beneficial
biofunctions of the extract for health promotion—antihy-
perlipidemic [11, 12], antihyperglycemic [12, 13],
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gastroprotective [13], and antiobesity effects [14] in vivo,
with antiallergic [15], pancreatic lipase inhibitory [16], and
amyroid b (Ab) aggregation inhibitory effects [17].
Here, we focused on the saponin constituents of the
flower bud extracts of C. sinensis cultivated in Japan (Ja-
panese Chaka), Anhui, Sichuan, and Fujian provinces of
China (Anhui, Sichuan and Fujian Chaka), and C. sinensis
var. assamica cultivated in India (Indian Assam Chaka)
and on their biofunctional effects. We further divided the
review into three parts—(A) Japanese and Anhui Chaka,
(B) Fujian Chaka, and (C) Indian Assam Chaka, based on
their saponin constituents and the variety of plant.
The biofunctional effects of Japanese and Anhui
Chaka
With regard to the biofunctional effects of Japanese and
Anhui Chaka, we documented the antihyperlipidemic,
antihyperglycemic, and gastroprotective effects of the
methanolic (MeOH) extract in mice and rats, and provided
findings on the antiallergic activity and inhibitory action of
pancreatic lipase, rat intestinal a-glucosidase, and rat lens
aldose reductase (in vitro).
Antihyperlipidemic and antihyperglycemic effects
With regard to antihyperlipidemic properties, we observed
the effect of the MeOH extract from Japanese and Anhui
Chaka on increased plasma triglyceride (TG) levels in olive
oil-loaded mice [11]. The MeOH extract (34.1 % from the
material) (500–1,000 mg/kg, p.o.) and n-BuOH-soluble
fraction (15.8 %) (500 mg/kg, p.o.) of Japanese Chaka
significantly inhibited increased plasma TG levels in olive
oil-loaded mice [11].
With regard to the antihyperglycemic properties, we
also observed the effect of the MeOH extract of Japanese
Chaka on increased serum glucose levels in sucrose-loaded
rats, rat intestinal a-glucosidase and rat lens aldose
reductase. Briefly, the MeOH extract (1,000 mg/kg, p.o)
and n-BuOH-soluble (500 mg/kg, p.o.) fraction signifi-
cantly inhibited plasma glucose elevation in rats. In addi-
tion, the extract significantly inhibited rat lens aldose
reductase (IC50 72 lg/mL), although inhibition of rat
intestinal a-glucosidase by the extract was weak [13].
In the course of our studies on the saponin composition of
tea plants, acylated oleanane-type triterpene oligoglyco-
sides, floratheasaponins A (1)–J (10), were isolated from
Japanese Chaka and Anhui Chaka, and their structures were
elucidated on the basis of chemical and physicochemical
evidence [11, 15, 18] (Fig. 1). However, although we were
not able to isolate floratheasaponins from Fujian Chaka,
instead we obtained chakasaponins I (11)–IV (14) [11, 16].
These findings were supported by qualitative and quantita-
tive analyses of floratheasaponins and chakasaponins in
Chaka from different regional origins. Briefly, the florath-
easaponin content in the Fujian and Sichuan Chaka is lower
than those in Japan, Taiwan, and India [13, 19]. Furthermore,
the floratheasaponin content in Japanese Chaka varies
markedly during the blooming periods, and is abundant at
half-bloom [13]. In addition, the caffeine content in the
flower buds is lower than the tea leaves [13].
Floratheasaponins A (1)–C (3) from Japanese Chaka at
50 and 100 mg/kg p.o. significantly inhibited TG elevation
in olive oil-loaded mice [11], and on serum glucose ele-
vation in sucrose-loaded rats [13] (Table 1). Comparing the
effects of 1–3 with those of theasaponins E1 and E2 from
the seeds of C. sinensis suggests that the 21 and 22-acyl
groups are essential, although the 23-aldehyde group is not
relevant to the antihyperlipidemic activity [11].
Gastromucosal protection
We further studied the protective effect of Japanese Chaka
on ethanol and indomethacin-induced gastric lesions in
rats. The MeOH extract (5–50 mg/kg) dose-dependently
inhibited gastric lesions, and floratheasaponins A (1)–C (3)
significantly inhibited ethanol-induced gastric lesions [13].
In fact, their effects were stronger than that of cetraxate
hydrochloride (used as a positive control; Table 2).
Antiallergic effects in vitro
Histamine, which is released frommast cells stimulated by an
antigen or a degranulation inducer, is usually determined as a
degranulation marker in in vitro experiments on immediate
allergic reactions. b-Hexosaminidase is also stored in secre-
tory granules of mast cells and basophils, and is also released
concomitantly with histamine when mast cells are immuno-
logically activated. Therefore, it is generally accepted that b-
hexosaminidase is a degranulation marker of mast cells, and
this assay has been used for the evaluation of antiallergic
compounds as an alternative to passive cutaneous anaphylaxis
reactions in laboratory animals [20].
Park et al. reported that the dammarane-type triterpene
glycoside, ginsenoside Rh2, exhibited inhibitory activity on
b-hexosaminidase release from rat basophilic leukemia
(RBL-2H3) cells, an activity suggested to originate from
cell membrane-stabilizing action [21]. Acylated oleanane-
type triterpene oligoglycosides, floratheasaponins A (1)–F
(6), were also expected to exhibit cell membrane-stabiliz-
ing action. Therefore, we examined the effects of these
floratheasaponins (1–6) on the release of b-hexosaminidase
induced by dinitrophenylated bovine serum albumin (DNP-
BSA) from RBL-2H3 cells sensitized with anti-DNP
immunoglobulin E.
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TheMeOH extract (38.5 % from the material) fromAnhui
Chaka exhibited a significant inhibitory effect on the release of
b-hexosaminidase from RBL-2H3 cells (inhibition
43.5 ± 2.4 % at 100 lg/mL, p\ 0.01). The ethyl acetate
(EtOAc)- and n-BuOH-soluble fractions inhibited antigen-
induced degranulation in RBL-2H3 cells at 100–30 lg/mL
(inhibition 18.1 ± 4.0 %, p\ 0.05 and 60.1 ± 2.9 %,
p\ 0.01, respectively), although theH2O-soluble fractiondid
not show such an effect. Floratheasaponins (1–6) were found
to show inhibitory effects on antigen-induced degranulation.
In particular, floratheasaponins B (2) and E (5) exhibited
significant inhibitory effects of 59.8 ± 3.6 % (p\ 0.01) and
52.3 ± 3.2 % (p\ 0.01) at 3 lM, respectively, and their
activities were, in fact, more potent than those of two antial-
lergic compounds, tranilast and ketotifen fumarate [15].
Biofunctional effects of Fujian Chaka
We investigated the effects of the antihyperlipidemic,
antihyperglycemic, and antiobesity properties of the MeOH
































































































































































































































































Fig. 1 Chemical structures of
acylated oleanane-type
triterpene oligoglycosides from
the flower buds of C. sinensis
cultivated in Japan and China,
and C. sinensis var. assamica
cultivated in India
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along with their ability to inhibit gastric emptying, and
accelerate gastrointestinal transit.
Antihyperlipidemic and antihyperglycemic effects
The MeOH extract (500 mg/kg, p.o.) of Fuijian Chaka also
inhibited plasma TG elevation in olive oil-loaded mice and
plasma glucose elevation in sucrose-loaded mice [12].
Chakasaponins I (11)–IV (14) isolated from Fujian Chaka,
and their chemical structures were determined [12, 16]. In
addition, chakasaponins V (15) and VI (16) together with
floratheasaponins A (1)–I (9), chakasaponins I (11)–III
(13), and assamsaponin E (25) were isolated from the dried
flower buds of C. sinensis cultivated in Sichuan province of
China (Sichuan Chaka) [22]. Chakasaponins I (11)–III (13)
from the n-BuOH-soluble fraction of Fujian Chaka at
50 mg/kg significantly inhibited plasma TG and glucose
elevation in mice [12] (Table 3), without affecting the
enzyme activity of rat intestinal a-glucosidase. The MeOH
extract and EtOAc- and n-BuOH-soluble fractions signifi-
cantly inhibited pancreatic lipase, and the IC50 values of
11–13 were 0.17, 0.18 and 0.53 mM, respectively, without
the desacyl derivative of 12 affecting it, suggesting that the
21 and 22-acyl groups are essential for the activity [16].
Antiobesity effects in high-fat diet-fed mice
and Tsumura Suzuki Obese Diabetes (TSOD) mice
The effects of the MeOH extract on body weight gain in
high-fat diet-fed mice and an experimental animal model of
metabolic syndrome, TSOD mice, have been reported [14].
The MeOH extract (500 mg/kg/day, p.o.) markedly inhib-
ited body weight gain 9–14 days after administration in
high-fat diet-fed mice (Fig. 2a). The MeOH extract (250
and/or 500 mg/kg/day, p.o.) significantly suppressed liver
weight, liver TG and the weight of visceral fat. A positive
control, bezafibrate (50 and 100 mg/kg/day, p.o.), signifi-
cantly reduced body weight gain (43.4 ± 0.9 g at 50 mg/
Table 1 Effects of
floratheasaponins A (1)–C (3)
on serum triglyceride (TG)
elevation in olive oil-loaded
mice and serum glucose
elevation in sucrose-loaded rats.
Data were taken and reproduced









Normal – 140.8 ± 5.9** 80.3 ± 2.7**
Control – 566.6 ± 22.2 147.6 ± 3.0
Floratheasaponin A (1) 25 411.0 ± 34.3 –
50 387.4 ± 74.7* 122.5 ± 8.8
100 158.3 ± 31.9** 107.3 ± 3.6**
Floratheasaponin B (2) 25 411.7 ± 50.6 –
50 316.9 ± 63.0** 120.3 ± 10.5
100 161.9 ± 11.9** 98.4 ± 7.2**
Floratheasaponin C (3) 25 348.5 ± 83.7** –
50 204.1 ± 40.3** 119.8 ± 7.9**
100 143.1 ± 11.3** 87.7 ± 5.5**
Normal – 154.3 ± 9.3** –
Control – 387.1 ± 39.2 –
Orlistat 6.25 266.4 ± 31.1* –
12.5 187.9 ± 25.5** –
25 158.9 ± 28.7** –
Normal – – 85.6 ± 3.6**
Control – – 159.6 ± 7.0
Metoformin hydrochloride 50 – 134.8 ± 4.3*
100 – 124.1 ± 5.5**
Effects on serum TG levels in mice: each test sample was given orally to fasted ddY male mice, and olive oil
(5 mL/kg, p.o.) was given 30 min later. Blood samples were collected at 2, 4, and 6 h after olive oil
treatment. Serum TG levels were determined by an enzymatic method using a commercially available kit
Effects on serum glucose levels in rats: each test sample was given orally to fasted male Wistar rats, and a
20 % (w/v) sucrose solution (5 mL/kg, p.o.) was given 30 min later. Blood samples were collected at 0.5, 1,
and 2 h after sucrose loading. Serum glucose levels were determined by an enzymatic method using a
commercially available kit
Values represent the mean ± SEM (n = 5–15)
Significant difference where *p\ 0.05 or **p\ 0.01 was compared with controls
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kg, p\ 0.05 and 43.0 ± 1.1 g at 100 mg/kg, p\ 0.05 vs
46.2 ± 0.5 g, control group) on day 14 after fasting. The
compound also reduced the weight of visceral fat and
plasma TG at 100 mg/kg. Peroxisome proliferator-acti-
vated receptor (PPAR)a agonists including bezafibrate are
reported to increase liver weight at higher doses in rats
[23]. Consistent with this report, an increase in liver weight
was observed in bezafibrate-treated mice. However, the
MeOH extract did not show such an effect, and this result
together with the lack of effect on plasma TG levels sug-
gested that the extract might not act as a PPARa agonist.
The extract (500 mg/kg/day, p.o.) also significantly
suppressed body weight gain of TSOD mice after one week
(Fig. 2b). Three weeks later, a glucose tolerance test was
performed using an intraperitoneal injection of glucose.
The MeOH extract (250–500 mg/kg/day, p.o.) significantly
suppressed an increase in plasma glucose levels 2 h after
glucose loading. After 4 weeks, liver weight, weight of
visceral fat, and plasma total cholesterol levels were sig-
nificantly suppressed by the extract (500 mg/kg/day, p.o.).
We speculated that the strong reduction of body
weight within a week after extract treatment was mainly
due to reduction of food intake. Therefore, the effect of
the extract on food intake was examined in high-fat diet-
fed mice and TSOD mice. As shown in Fig. 3a and b,
the extract inhibited food intake in a dose-dependent
manner. Furthermore, this effect was also observed in
normal diet-fed mice; the total intake for 5 days in the
MeOH extract-treated group (500 mg/kg/day, p.o.) was
19.3 g (p\ 0.01) vs 21.0 g in the control group,
although an obvious toxic effect was not observed (ex-
cept for body weight gain) [14].
Next, we examined the n-BuOH-, ethyl acetate
(EtOAc)- and H2O-soluble fractions from the MeOH
extract. The n-BuOH-soluble fraction (16.4 % from the
material) inhibited food intake at a dose of 250 mg/kg/day,
p.o. (Fig. 4a), but the EtOAc- and H2O-soluble fractions
(3.2 and 11.5 % from the material) had no such effect,
when the fraction was given orally according to its yield.
With regard to the effect of the n-BuOH-soluble fraction
on appetite signals, the effects on neuropeptide Y (NPY)
and agouti-related protein (AgRP) mRNA levels in the
hypothalamus were examined. NPY is an important regu-
lator of body weight through its effects on food intake and
energy expenditure. The majority of neurons expressing
NPY in the hypothalamus are found within the arcuate
Table 2 Inhibitory effects of
floratheasaponins A (1)–C (3)
on gastric lesions induced by
ethanol in rats. Data were taken





Length (mm) Inhibition (%)
Control – 157.0 ± 15.5 –
Floratheasaponin A (1) 5 80.2 ± 14.7 48.9
10 72.9 ± 11.1** 57.7
20 24.2 ± 10.2** 88.4
50 0.0 ± 0.0** 100.0
Floratheasaponin B (2) 5 92.8 ± 24.2 40.9
10 55.4 ± 12.2** 64.7
20 24.9 ± 10.5** 84.1
50 11.5 ± 7.7** 92.7
Control – 163.3 ± 10.3 –
Floratheasaponin C (3) 5 38.0 ± 7.1** 76.7
10 22.3 ± 6.8** 86.3
20 18.5 ± 7.2** 88.7
50 0.0 ± 0.0 100.0
Control – 148.4 ± 9.8 –
Cetraxate hydrochloride 75 87.2 ± 7.4** 41.2
150 51.0 ± 4.0** 65.6
300 30.5 ± 8.3** 79.4
Ethanol (99.5 %, 1.5 mL/rat, p.o.) was given to fasted male Sprague–Dawley rats 1 h before removal of the
stomach, which was previously inflated by an injection of 10 ml of 1.5 % formalin to fix the inner and outer
layers of the gastric walls. Subsequently, the stomach was incised along the greater curvature and the
lengths of gastric lesions were measured, and the total length (mm) was expressed as a lesion index. The
test sample was administered 1 h before the ethanol treatment
Values represent the mean ± SEM (n = 6–12)
Significant difference where **p\ 0.01 was compared with controls
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nucleus (ARC) and most co-express AgRP. The ablation of
NPY/AgRP neurons in young mice reduces food intake and
body weight, and an intracerebroventricular injection of
NPY potently stimulates food intake in adult rats [24]. In
our study, the n-BuOH-soluble fraction administrated at
250 mg/kg for 4 days significantly suppressed the expres-
sion of NPY mRNA (Fig. 5). These findings suggest that
the n-BuOH-soluble fraction inhibited food intake by
suppressing appetite signals.
Furthermore, a principal saponin, chakasaponin II (12),
induced a similar suppression of food intake (50 mg/
kg/day, p.o.) (Fig 4b). In addition, 12 (50 mg/kg/day, p.o.)
significantly inhibited NPY mRNA levels in the hypotha-
lamus similar to the n-BuOH-soluble fraction (Fig. 5).
These results suggest that the saponins are active con-
stituents of the extract. Furthermore, the desacyl derivative
of 12, desacyl-floratheasaponin B, failed to produce the
effect (Fig. 4c), suggesting that the 21 and 22-acyl groups
are important for the activity.
Recently, an anti-cancer drug, cisplatin, and selective
serotonin reuptake inhibitors (SSRIs) have been reported to
inhibit food intake, and the involvement of 5-hydrox-
ytryptamine 2 (5-HT2) receptors in appetite control has been
shown. Appetite is suppressed when the 5-HT2B receptor in
Table 3 Effects of
chakasaponins I (11)—III (13)
and escin IIa on plasma
triglyceride (TG) and glucose
elevations in olive oil and
sucrose-loaded mice. Data were










Normal – 115.5 ± 12.4** 128.5 ± 5.3**
Control – 440.5 ± 45.2 226.9 ± 8.2
Chakasaponin I (11) 25 435.7 ± 67.4 –
50 284.2 ± 9.6** 199.6 ± 8.7**
100 – 196.8 ± 8.2**
Normal – 152.4 ± 13.5** 116.5 ± 7.9**
Control – 553.8 ± 49.8 221.5 ± 14.4
Chakasaponin II (12) 25 431.8 ± 49.8** –
50 249.5 ± 31.1** 185.7 ± 9.9**
100 – 178.5 ± 8.3**
Normal – 124.0 ± 8.4** 126.5 ± 4.0**
Control – 407.2 ± 73.0 238.7 ± 5.9
Chakasaponin III (13) 25 394.1 ± 81.4 –
50 214.4 ± 62.7* 215.9 ± 10.6**
100 – 189.0 ± 10.2**
Normal – 91.9 ± 9.4** –
Control – 440.3 ± 60.2 –
Orlistat 5 371.3 ± 41.5 –
10 203.8 ± 52.1** –
Normal – – 124.8 ± 7.3**
Control – – 218.7 ± 4.0
Acarbose 10 – 162.4 ± 11.7**
20 – 153.8 ± 10.2**
Normal – 114.9 ± 18.1** 122.2 ± 6.3**
Control – 546.7 ± 59.4 263.3 ± 16.2
Escin IIa 50 464.2 ± 45.3 254.2 ± 14.0
100 308.9 ± 61.4* 206.4 ± 12.9**
Effects on plasma TG levels in mice: each test sample was given orally to fasted male ddY mice and olive
oil (5 mL/kg, p.o.) was given 30 min later. Blood samples were collected at 2, 4, and 6 h after olive oil
treatment. Plasma TG levels were determined by an enzymatic method using a commercially available kit
Effects on plasma glucose levels in mice: each test sample was given orally to fasted male ddY mice, and a
10 (w/v) % sucrose solution (10 mL/kg, p.o.) was given 30 min later. Blood samples were collected at 0.5,
1, and 2 h after sucrose loading. Plasma glucose levels were determined by an enzymatic method using a
commercially available kit
Values represent the mean ± SEM (n = 5–9)
Significant difference where *p\ 0.05 or **p\ 0.01 was compared with controls
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gastric smooth muscle and the 5-HT2C receptor in the
hypothalamus are activated. 5-HT produced during treatment
with cisplatin or SSRIs binds to various receptor subtypes and
is likely to stimulate 5-HT2B and 5-HT2C receptors. Stimula-
tion of 5-HT2B receptor decreases plasma ghrelin levels, and
suppresses appetite signals via afferent vagal nerves [25–27].
Consistent with previous reports, 5-HT (serotonin creatinine
sulfate monohydrate, 1 mg/kg, i.p.) inhibited food intake in
mice (Fig. 4d). In our study, we investigated the release of
5-HT from isolated ilea ofmice and its retention in the tissues.
Chakasaponin II (12) at 1.0 mM significantly enhanced the
release of 5-HT into the medium and reduced its retention in
the tissues [14]. This concentration is relatively high, but
concentrations of saponin in the intestinal tract are thought to
be generally high, since this type of compound is difficult to be
absorbed [28]. Furthermore, the effects of n-BuOH-soluble
fraction and chakasaponin II (12) on food intake were
obviously reduced in the capsaicin-pretreated mice in which
the capsaicin-sensitive sensory nerves were densensitized by
pretreatment with a high dose of capsaicin (Fig. 4a, b). In our
pre-examination, chakasaponin II (12) increased plasma
cholecystokinin (CCK) and glucagon-like peptide-1 (GLP-1)
levels in mice (Table 4). CCK and GLP-1 are known to
influence satiety signals secreted from intestinal I-cells and
L-cells [29]. These findings suggest that their inhibitory
effects on food intake were initiated by excretion of CCK and
GLP-1, and were mediated via capsaicin-sensitive sensory
nerves, probably the afferent vagal nerves (Fig. 6).
Effects on gastric emptying in mice
Previously, several saponins with similar structures, escins
from the seeds of A. turbinata, were documented to show


















































(a) Effect on body weight gain in high-fat diet-fed mice
(b) Effect on  body weight gain  in TSOD mice
Fig. 2 Effects of the MeOH
extract of Fujian Chaka on body
weight gain in high-fat diet-fed
mice and Tsumura Suzuki
Obese Diabetes (TSOD) mice.
a Male ddY mice were fed a
high-fat diet (45 kcal % fat,
D12451; Research Diet, Inc.) or
normal diet (10 kcal % fat,
D12450B; Research Diet, Inc.)
for 14 days. The test sample
was given orally once a day.
b TSOD and Tsumura Suzuki
Non-obesity (TSNO) mice were
fed a standard laboratory chow
MF (Oriental Yeast Co., Ltd.)
for 28 days. The test sample
was given orally once a day.
Each value represents the mean
with SEM (n = 6–10).
Significant difference where
*p\ 0.05 or **p\ 0.01 was
compared with controls. Data
were taken from reference [14]
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and inhibition of pancreatic lipase activity is suggested to
be partly involved in this effect [30]. However, we con-
sidered that their antihyperlipidemic effects are mainly
dependent on the inhibition of gastric emptying [31]. We,
therefore, examined the effects of the MeOH extract and its
n-BuOH-soluble fraction on gastric emptying in mice. The
amount of phenol red in the stomach was determined
30 min after oral administration of carboxymethyl cellu-
lose sodium salt (CMC-Na) containing phenol red.
The MeOH extract (125–500 mg/kg, p.o.) and n-BuOH-
soluble fraction (125–250 mg/kg, p.o.) significantly inhib-
ited gastric emptying in a dose-dependent manner. Fur-
thermore, chakasaponins I (11) and II (12) (25–50 mg/kg)
also inhibited gastric emptying in mice [12, 14] (Table 5).
In a previous report, we observed that the inhibitory
effects of escins on gastric emptying involved the release
of dopamine and dopamine2 receptors via mechanisms
involving capsaicin-sensitive sensory nerves, probably
certain vagal afferent nerves [32]. Tominaga et al. reported
that 5-HT inhibited gastric emptying in rats [33]. Consis-
tent with the previous report, 5-HT (serotonin creatinine
sulfate monohydrate, 10 mg/kg, i.p.) significantly inhibited
gastric emptying under our experimental conditions,
although the effective dose of 5-HT was higher than for
food intake [14].
As described above, the inhibitory effects of escins on
gastric emptying involved the capsaicin-sensitive sensory
nerves, probably certain vagal afferent nerves [31]. Pre-
treatmentwith capsaicin partly reduced the inhibitory effects
of the n-BuOH-soluble fraction and chakasaponins I (11) and
II (12) on gastric emptying, suggesting that certain afferent
vagal nerves are involved, at least in part, in the inhibition of
gastric emptying as well as food intake. Bugajski et al.
observed that long-term vagal electrical stimulation reduces
food intake and body weight in rats [34]. Therefore, in
addition to release of 5-HT, CCK, and GLP-1, other mech-
anisms of action including the direct stimulation of the vagal
nerves by saponins warrant further study.
Acceleration of gastrointestinal transit
Gastrointestinal transit accelerating effects are thought to
be beneficial for the prevention and treatment of the inhi-


























































Fig. 3 Effects of the MeOH
extract of Fujian Chaka on food
intake in high-fat diet-fed mice
and TSOD mice. a Male ddY
mice were fed a high-fat diet
(45 kcal % fat) or normal diet
(10 kcal % fat) for 14 days. The
test sample was given orally
once a day. b TSOD and TSNO
mice were fed a standard
laboratory chow MF (Oriental
Yeast Co., Ltd.) for 28 days.
The test sample was given
orally once a day. Each value
represents the mean for 6–10
mice. Significant difference
where *p\ 0.05 or **p\ 0.01
was compared with controls.
Refer to Fig. 2 for other
abbreviations. Data were taken
from reference [14]
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ileus in clinical situations. We have previously reported
that escins and theasaponin E1 showed similar effects as
those of the seeds of A. hippocastanum and C. sinensis var.
assamica [4, 35] which also have similar structures. The
MeOH extract (500 mg/kg, p.o.) and n-BuOH-soluble
fraction (200 mg/kg, p.o.) from Fujian Chaka displayed an
accelerating effect on gastrointestinal transit in mice. In a
similar fashion, chakasaponins I (11)–III (13) (50 or
100 mg/kg, p.o.) also demonstrated such accelerating
effects [16] (Table 5).
Saponin constituents and biofunctional effects
of Indian Assam Chaka
Eight acylated oleanane-type triterpene oligoglycosides,
floraassamsaponins I (17)–VIII (24), together with flo-
ratheasaponins D (4), G (7) and I (9), were isolated from
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Fig. 4 Effects of the BuOH-soluble fraction of Fujian Chaka,
chakasaponin II (12), desacyl-floratheasaponin B, and 5-HT on food
intake in normal mice and/or capsaicin-pretreated mice. Male ddY
mice were fed a standard laboratory chow MF (Oriental Yeast Co.,
Ltd.) for 8 days. The test sample was given orally once a day.
b, c These doses are equivalent to approximately 0.2–0.4 mg/kg
serotonin. Each value represents the mean of 5 or 6 mice. Significant
differences where **p\ 0.01 and p\ 0.05 or p\ 0.01 were
compared with controls and capsaicin-treated group, respectively.
Data were taken from reference [14]
Fig. 5 Effects of n-BuOH-soluble fraction and chakasaponin II (12)
on neuropeptide Y (NPY) mRNA levels in mice. The test sample was
given orally to male ddY mice once a day. Four days later, the
hypothalamus was dissected out, and the NPY mRNA levels were
determined using real-time polymerase chain reaction. Each bar
represents the mean ± SEM (n = 6). Significant difference where
*p\ 0.05 or **p\ 0.01 was compared with controls. Data were
taken and reproduced from reference [14]
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Indian Assam Chaka, the flower buds of C. sinensis var.
assamica, and their chemical structures were determined.
Floraassamsaponins I (17) and II (18) have a sugar moiety
at the 28-position, although other acylated oleanane-type
triterpene oligoglycosides from Japanese and Chinese
Chakas do not have a sugar moiety at this position.
With regard to new biofunctional effects of Indian
Assam Chaka, the effect on 42-mer amyloid b-protein
(Ab42) aggregation in vitro was examined using the
Thioflavin T method. Alzheimer’s disease is a neurode-
generative disorder characterized by Ab42 aggregation.
Previously, various phenolic constituents such as flavo-
noids and caffeoylquinic acids inhibited Ab42 aggregation,
although studies on this type of saponins have not been
attempted [36–38]. The n-BuOH-soluble fraction and flo-
raassamsaponins III (19), IV (20), and VII (23) signifi-
cantly inhibited Ab42 aggregation (inhibition 19:
73.4 ± 8.0 %, p\ 0.01; 20: 68.8 ± 8.4 %, p\ 0.01; and
23: 56.9 ± 13.2 %, p\ 0.01 at 100 lM, respectively).
Their effects were almost equivalent to significant sup-
pression of a positive control, morin (inhibition
54.0 ± 11.2 %, p\ 0.01 at 100 lM), which is known to
be one of the most potent natural compounds with inhibi-
tory effects [37]. Further studies (including in vivo inves-
tigations) are needed, since this type of compound shows
less absorption as described above [28].
In conclusion, we have described the actions of new
saponins (classified as acylated oleanane-type triterpene
oligoglycosides), which were isolated from Japanese,
Anhui, Sichun, and Fujian Chaka and Indian Assam Chaka.
Biofunctions beneficial for health promotion, such as
antihyperlipidemic, antihyperglycemic, antiobesity, and
gastroprotective effects in mice and rats, as well as
antiallergic, pancreatic lipase inhibitory, and Ab42 aggre-
gation inhibitory activities (in vitro) of the extract and
newly identified saponin constituents (floratheasaponins,
chakasaponin, and floraassamsaponins) were revealed.
Furthermore, various bioactive flavonol glycosides and
epicatechines, etc. were isolated from each Chaka
[11, 12, 15, 16, 18, 22], apart from their quantitative
analyses reported previously [39, 40]. On the basis of this
Table 4 Effects of
chakasaponin II (12) on plasma









Control – 1.31 ± 0.06 20.0 ± 3.4 419 ± 25
Chakasaponin II (12) 25 1.19 ± 0.08 25.3 ± 4.6 681 ± 70**
50 1.02 ± 0.06** 37.3 ± 9.9* 702 ± 112**
Male ddY mice (6 weeks old) were fed a high-fat diet (45 kcal % fat, D12451; Research Diets Inc.) for
7 days before the experiments. Test samples were given orally to the fasted mice 45 min before the mid-
light satiety test. The high-fat diet was then given to the mice for 30 min, and the food intake within the
30-min period was measured for each group. A blood sample was collected from the portal vein under
anesthesia, and plasma GLP-1 and CCK levels were measured by ELISA kits. Refer to Fig. 6 for
abbreviations
Values represent the mean ± SEM (n = 7 or 8)
Significant difference where *p\ 0.05 or **p\ 0.01 was compared with controls
Fig. 6 Appetite signals in the gastrointestinal-brain system. NPY
neuropeptide Y, AgRP agouti-related protein, MSH melanocyte-
stimulating hormone, POMC proopiomelanocortin, NTS nucleus
tractus solitaries, ARC arcuate nucleus, PVN paraventricular nucleus,
LHA lateral hypothalamic area, CCK cholescystokinin, GLP-1
glucagon-like peptide 1. CCK and GLP-1 secreted from the intestinal
I-cells and L-cells stimulate each receptor and the signals are
mediated through the afferent vagal nerves and NTS to reduce the
expression of NPY and AgRP, and finally reduce the appetite.
Stimulation of 5-HT2B receptor in the stomach by 5-HT from
chromaffin cells in the intestine inhibits the release of ghrelin which
stimulates the appetite through the afferent vagal nerves, and
stimulation of the 5HT2C receptor in the hypothalamus stimulates
POMC neurons to reduce the appetite
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experimental evidence, a variety of health/functional foods
and beverages made of Chaka have been developed
recently in Japan and Taiwan.
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